{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T23:37:24Z","timestamp":1791589044232,"version":"4.3.4"},"reference-count":26,"publisher":"American Medical Association (AMA)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"Importance<\/jats:title>Asymptomatic hemorrhagic infarction (HI) and subarachnoid hemorrhage (SAH) after endovascular treatment (EVT) for acute ischemic stroke are commonly considered low risk, but their long-term impact on functional outcomes is unclear.<\/jats:p><\/jats:sec>Objective<\/jats:title>To determine whether asymptomatic HI and SAH are associated with worse 90-day functional recovery in patients with acute ischemic stroke treated with EVT.<\/jats:p><\/jats:sec>Design, Setting, and Participants<\/jats:title>This is a secondary analysis of the DIRECT-MT randomized clinical trial, which compared intravenous thrombolysis prior to EVT with EVT alone. The multicenter study was conducted at tertiary hospitals in China between 2016 and 2019 with 90-day follow-up. Trial patients with asymptomatic HI, SAH, or no hemorrhage were included in the present analysis, which was performed in December 2024.<\/jats:p><\/jats:sec>Exposure<\/jats:title>Asymptomatic HI and SAH detected on follow-up imaging.<\/jats:p><\/jats:sec>Main Outcomes and Measures<\/jats:title>The primary outcome was the score on the modified Rankin scale (mRS) assessed at 90 days. Secondary analyses categorized mRS scores into thresholds of 0 to 1, 0 to 2, and 0 to 3, representing excellent, good, and favorable recovery, respectively.<\/jats:p><\/jats:sec>Results<\/jats:title>A total of 490 patients were included (median [IQR] age, 70 [60-76] years; 210 [42.9%] female), with 133 (27.1%) in the asymptomatic HI and SAH group and 357 (72.9%) in the no hemorrhage group. After propensity score matching, the odds ratio of having a worse mRS scores at 90 days in the asymptomatic HI and SAH group compared with the no hemorrhage group was 2.59 (95% CI, 1.45-4.63; P<\/jats:italic>\u2009=\u2009.001). For binary outcomes, asymptomatic HI and SAH were consistently associated with worse recovery across mRS score thresholds of 0 to 1 and 0 to 2 in all models.<\/jats:p><\/jats:sec>Conclusions and Relevance<\/jats:title>In this secondary analysis of a randomized clinical trial, asymptomatic HI and SAH were associated with worse 90-day functional outcomes in patients with acute ischemic stroke treated with EVT. These findings emphasize the need for close monitoring and tailored management strategies in patients with asymptomatic hemorrhagic events following thrombectomy.<\/jats:p><\/jats:sec>Trial Registration<\/jats:title>ClinicalTrials.gov Identifier: NCT03469206<\/jats:ext-link><\/jats:p><\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2025.2411","type":"journal-article","created":{"date-parts":[[2025,3,28]],"date-time":"2025-03-28T19:17:07Z","timestamp":1743189427000},"page":"e252411","source":"Crossref","is-referenced-by-count":13,"title":["Asymptomatic Hemorrhagic Events and Functional Outcomes in Acute Stroke"],"prefix":"10.1001","volume":"8","author":[{"given":"Rundong","family":"Chen","sequence":"first","affiliation":[{"name":"School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, China"},{"name":"Neurovascular Center, Changhai Hospital, Naval Medical University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weilong","family":"Hua","sequence":"additional","affiliation":[{"name":"Neurovascular Center, Changhai Hospital, Naval Medical University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yilei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Nursing Department, Sir Run Run Shaw Hospital, Zhejiang University School of Medicine, Hangzhou, China"},{"name":"Oriental Pan-Vascular Devices Innovation College, University of Shanghai for Science and Technology, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongxin","family":"Zhang","sequence":"additional","affiliation":[{"name":"Neurovascular Center, Changhai Hospital, Naval Medical University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjian","family":"Zhang","sequence":"additional","affiliation":[{"name":"Oriental Pan-Vascular Devices Innovation College, University of Shanghai for Science and Technology, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongwei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Neurovascular Center, Changhai Hospital, Naval Medical University, Shanghai, China"},{"name":"Oriental Pan-Vascular Devices Innovation College, University of Shanghai for Science and Technology, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianmin","family":"Liu","sequence":"additional","affiliation":[{"name":"School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, China"},{"name":"Neurovascular Center, Changhai Hospital, Naval Medical University, Shanghai, China"},{"name":"Oriental Pan-Vascular Devices Innovation College, University of Shanghai for Science and Technology, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pengfei","family":"Yang","sequence":"additional","affiliation":[{"name":"School of Health Science and Engineering, University of Shanghai for Science and Technology, Shanghai, China"},{"name":"Neurovascular Center, Changhai Hospital, Naval Medical University, Shanghai, China"},{"name":"Oriental Pan-Vascular Devices Innovation College, University of Shanghai for Science and Technology, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxi","family":"Zhang","sequence":"additional","affiliation":[{"name":"Neurovascular Center, Changhai Hospital, Naval Medical University, Shanghai, China"},{"name":"State Key Laboratory of Medical Neurobiology and MOE Frontiers Center for Brain Science, Institutes of Brain Science, Shanghai Medical College, Fudan University, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Zhang","sequence":"additional","affiliation":[{"name":"Neurovascular Center, Changhai Hospital, Naval Medical University, Shanghai, China"},{"name":"Oriental Pan-Vascular Devices Innovation College, University of Shanghai for Science and Technology, Shanghai, China"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2025,3,28]]},"reference":[{"issue":"10","key":"zoi250137r1","doi-asserted-by":"publisher","first-page":"971","DOI":"10.1136\/jnis-2022-019474","article-title":"Type of intracranial hemorrhage after endovascular stroke treatment: association with functional outcome.","volume":"15","author":"van der Steen","year":"2023","journal-title":"J Neurointerv Surg"},{"issue":"4","key":"zoi250137r2","doi-asserted-by":"publisher","DOI":"10.1161\/JAHA.123.031749","article-title":"Asymptomatic intracerebral hemorrhage following endovascular stroke therapy is not benign: a systematic review and meta-analysis.","volume":"13","author":"Harker","year":"2024","journal-title":"J Am Heart Assoc"},{"issue":"10","key":"zoi250137r3","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1161\/STROKEAHA.115.010049","article-title":"The Heidelberg Bleeding Classification: classification of bleeding events after ischemic stroke and reperfusion therapy.","volume":"46","author":"von Kummer","year":"2015","journal-title":"Stroke"},{"key":"zoi250137r4","doi-asserted-by":"publisher","DOI":"10.1136\/jnis-2024-022048","article-title":"Acute ischemic stroke with or without asymptomatic intracranial hemorrhage after endovascular treatment: a propensity-score matching study.","author":"Zhang","year":"2025","journal-title":"J Neurointerv Surg"},{"issue":"5","key":"zoi250137r5","doi-asserted-by":"publisher","first-page":"464","DOI":"10.1136\/neurintsurg-2018-014141","article-title":"Hemorrhagic transformation is associated with poor functional outcome in patients with acute ischemic stroke due to a large vessel occlusion.","volume":"11","author":"van Kranendonk","year":"2019","journal-title":"J Neurointerv Surg"},{"issue":"21","key":"zoi250137r6","doi-asserted-by":"publisher","first-page":"1981","DOI":"10.1056\/NEJMoa2001123","article-title":"Endovascular thrombectomy with or without intravenous alteplase in acute stroke.","volume":"382","author":"Yang","year":"2020","journal-title":"N Engl J Med"},{"issue":"2","key":"zoi250137r7","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1161\/STROKEAHA.116.015434","article-title":"Using the National Institutes of Health Stroke Scale: a cautionary tale.","volume":"48","author":"Lyden","year":"2017","journal-title":"Stroke"},{"issue":"9","key":"zoi250137r8","doi-asserted-by":"publisher","first-page":"3054","DOI":"10.1161\/STROKEAHA.121.034480","article-title":"Standardized nomenclature for modified Rankin Scale global disability outcomes: consensus recommendations from Stroke Therapy Academic Industry Roundtable XI.","volume":"52","author":"Saver","year":"2021","journal-title":"Stroke"},{"issue":"12","key":"zoi250137r9","doi-asserted-by":"publisher","first-page":"e344","DOI":"10.1161\/STR.0000000000000211","article-title":"Guidelines for the early management of patients with acute ischemic stroke: 2019 update to the 2018 guidelines for the early management of acute ischemic stroke: a guideline for healthcare professionals from the American Heart Association\/American Stroke Association.","volume":"50","author":"Powers","year":"2019","journal-title":"Stroke"},{"issue":"19","key":"zoi250137r10","doi-asserted-by":"publisher","first-page":"3388","DOI":"10.1002\/sim.5753","article-title":"A tutorial on propensity score estimation for multiple treatments using generalized boosted models.","volume":"32","author":"McCaffrey","year":"2013","journal-title":"Stat Med"},{"issue":"6","key":"zoi250137r11","doi-asserted-by":"publisher","first-page":"884","DOI":"10.1007\/s00134-018-5208-7","article-title":"Transthoracic echocardiography and mortality in sepsis: analysis of the MIMIC-III database.","volume":"44","author":"Feng","year":"2018","journal-title":"Intensive Care Med"},{"issue":"12","key":"zoi250137r12","doi-asserted-by":"publisher","first-page":"1095","DOI":"10.1136\/neurintsurg-2020-017123","article-title":"Association of asymptomatic hemorrhage after endovascular stroke treatment with outcomes.","volume":"13","author":"Feldman","year":"2021","journal-title":"J Neurointerv Surg"},{"issue":"1","key":"zoi250137r13","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1111\/ene.14539","article-title":"Prognosis and risk factors associated with asymptomatic intracranial hemorrhage after endovascular treatment of large vessel occlusion stroke: a prospective multicenter cohort study.","volume":"28","author":"Constant Dit Beaufils","year":"2021","journal-title":"Eur J Neurol"},{"key":"zoi250137r14","doi-asserted-by":"publisher","DOI":"10.1177\/15266028231219990","article-title":"Prognosis and Prediction of Asymptomatic Intracranial Hemorrhage After Endovascular Thrombectomy: A Multi-Center Study.","author":"Kang","year":"2023","journal-title":"J Endovasc Ther"},{"issue":"7","key":"zoi250137r15","doi-asserted-by":"publisher","first-page":"3470","DOI":"10.1007\/s00415-022-11046-6","article-title":"Prognosis associated with asymptomatic intracranial hemorrhage after acute ischemic stroke: a systematic review and meta-analysis.","volume":"269","author":"Tang","year":"2022","journal-title":"J Neurol"},{"key":"zoi250137r16","doi-asserted-by":"publisher","DOI":"10.1016\/j.jns.2024.122868","article-title":"The effect of asymptomatic intracranial hemorrhage after mechanical thrombectomy on clinical outcome.","volume":"457","author":"Suzuki","year":"2024","journal-title":"J Neurol Sci"},{"issue":"6","key":"zoi250137r17","doi-asserted-by":"publisher","first-page":"1144","DOI":"10.4103\/1673-5374.300330","article-title":"Motor tract reorganization after acute central nervous system injury: a translational perspective.","volume":"16","author":"Takase","year":"2021","journal-title":"Neural Regen Res"},{"issue":"12","key":"zoi250137r18","doi-asserted-by":"publisher","first-page":"1166","DOI":"10.2174\/1570159X1812201102145717","article-title":"Blood-brain barrier dysfunction in cerebrovascular diseases.","volume":"18","author":"Hu","year":"2020","journal-title":"Curr Neuropharmacol"},{"issue":"6","key":"zoi250137r19","doi-asserted-by":"publisher","first-page":"634","DOI":"10.1016\/j.jalz.2016.09.006","article-title":"Blood-brain barrier failure as a core mechanism in cerebral small vessel disease and dementia: evidence from a cohort study.","volume":"13","author":"Wardlaw","year":"2017","journal-title":"Alzheimers Dement"},{"key":"zoi250137r20","doi-asserted-by":"publisher","first-page":"524","DOI":"10.1016\/j.redox.2015.08.020","article-title":"Reperfusion injury and reactive oxygen species: the evolution of a concept.","volume":"6","author":"Granger","year":"2015","journal-title":"Redox Biol"},{"issue":"6","key":"zoi250137r21","doi-asserted-by":"publisher","first-page":"7204","DOI":"10.18632\/oncotarget.23208","article-title":"Inflammatory responses and inflammation-associated diseases in organs.","volume":"9","author":"Chen","year":"2017","journal-title":"Oncotarget"},{"issue":"12","key":"zoi250137r22","doi-asserted-by":"publisher","first-page":"1023","DOI":"10.1016\/S1474-4422(20)30364-1","article-title":"Neuroinflammation in intracerebral haemorrhage: immunotherapies with potential for translation.","volume":"19","author":"Xue","year":"2020","journal-title":"Lancet Neurol"},{"issue":"2","key":"zoi250137r23","doi-asserted-by":"publisher","first-page":"294","DOI":"10.1016\/j.expneurol.2007.05.014","article-title":"CNS injury, glial scars, and inflammation: inhibitory extracellular matrices and regeneration failure.","volume":"209","author":"Fitch","year":"2008","journal-title":"Exp Neurol"},{"issue":"1","key":"zoi250137r24","doi-asserted-by":"publisher","first-page":"65","DOI":"10.2174\/157015909787602823","article-title":"Oxidative stress and neurodegenerative diseases: a review of upstream and downstream antioxidant therapeutic options.","volume":"7","author":"Uttara","year":"2009","journal-title":"Curr Neuropharmacol"},{"issue":"10363","key":"zoi250137r25","doi-asserted-by":"publisher","first-page":"1585","DOI":"10.1016\/S0140-6736(22)01882-7","article-title":"Intensive blood pressure control after endovascular thrombectomy for acute ischaemic stroke (ENCHANTED2\/MT): a multicentre, open-label, blinded-endpoint, randomised controlled trial.","volume":"400","author":"Yang","year":"2022","journal-title":"Lancet"},{"issue":"7","key":"zoi250137r26","doi-asserted-by":"publisher","first-page":"e282","DOI":"10.1161\/STR.0000000000000407","article-title":"2022 Guideline for the management of patients with spontaneous intracerebral hemorrhage: a guideline from the American Heart Association\/American Stroke Association.","volume":"53","author":"Greenberg","year":"2022","journal-title":"Stroke"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2832011\/chen_2025_oi_250137_1744907402.18041.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,4,28]],"date-time":"2025-04-28T15:00:31Z","timestamp":1745852431000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2832011"}},"subtitle":["A Secondary Analysis of the DIRECT-MT Randomized Clinical Trial"],"short-title":[],"issued":{"date-parts":[[2025,3,28]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2025.2411","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,3,28]]}}}